Potent neutralization of primary HIV-1 isolates by antibodies directed against epitopes present in the V1/V2 domain of HIV-1 gp120

By Pinter A.   Honnen W.J.   Kayman S.C.   Trochev O.   Wu Z.  

Vaccine, Vol. 16, Iss. 19, 1998-11 ,pp. : 1803-1811

Elsevier

Access to resources Recommend Favorite

A molecular and serologic study of the envelope gene of the British isolate: HIV-1 GB8

By Vella C.   Smith M.H.   Farrar G.H.   Jones D.H.   Daniels R.S.  

Vaccine, Vol. 13, Iss. 8, 1995-06 ,pp. : 735-741

Elsevier

Access to resources Recommend Favorite

Recognition of HIV-derived B and T cell epitopes displayed on filamentous phages

By De Berardinis P.   D'Apice L.   Prisco A.   Ombra M.N.   Barba P.   Del Pozzo G.   Petukhov S.   Malik P.   Perham R.N.   Guardiola J.  

Vaccine, Vol. 17, Iss. 11, 1999-03 ,pp. : 1434-1441

Elsevier

Access to resources Recommend Favorite

Vaccine-induced antibodies to the native, oligomeric envelope glycoproteins of primary HIV-1 isolates

By Lee S.A.   Orque R.   Escarpe P.A.   Peterson M.L.   Good J.W.   Zaharias E.M.   Berman P.W.   Sheppard H.W.   Shibata R.  

Vaccine, Vol. 20, Iss. 3, 2001-11 ,pp. : 563-576

Elsevier

Access to resources Recommend Favorite

The organization of human leucocyte antigen class I epitopes in HIV genome products: implications for HIV evolution and vaccine design

By Chao Z.   Cornette J.L.   Berzofsky J.A.   DeLisi C.  

Vaccine, Vol. 15, Iss. 12, 1997-08 ,pp. : 1291-1302

Elsevier

Access to resources Recommend Favorite